Influence of major antiepileptic drugs on neuropsychological function: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients on monotherapy
- PMID: 17445287
- DOI: 10.1017/S1355617707070555
Influence of major antiepileptic drugs on neuropsychological function: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients on monotherapy
Abstract
The aim of this study was to assess cognitive effects of anticonvulsants in a way that would yield results that are most directly applicable to epilepsy populations. This was done with a placebo-controlled, prospective, randomized, double-blind, parallel group study of anticonvulsant withdrawal in a population of subjects taking a single anticonvulsant with completely controlled seizures. Outcomes of this study on cognitive measures from the California Computerized Assessment Package have recently been reported. To aid comparison with results of prior studies, we report outcomes here on several more standard measures of neuropsychological function. The major findings were that, in subjects with therapeutic drug levels at baseline, drug withdrawal was associated with significant improvement in performance on the Controlled Oral Word Association Test and the Stroop Color-Word Interference Test. Comparable results were achieved in the subgroup taking carbamazepine.
Similar articles
-
Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.Epilepsia. 2006 Dec;47(12):2038-45. doi: 10.1111/j.1528-1167.2006.00805.x. Epilepsia. 2006. PMID: 17201701 Clinical Trial.
-
Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).Epilepsia. 2008 Mar;49(3):455-63. doi: 10.1111/j.1528-1167.2007.01323.x. Epub 2007 Sep 19. Epilepsia. 2008. PMID: 17888074 Clinical Trial.
-
Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functions.Acta Neurol Scand. 2009 Mar;119(3):194-8. doi: 10.1111/j.1600-0404.2008.01109.x. Epub 2008 Oct 21. Acta Neurol Scand. 2009. PMID: 18976320 Clinical Trial.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Historical control withdrawal to monotherapy.Epilepsy Res. 2006 Jan;68(1):74-7. doi: 10.1016/j.eplepsyres.2005.09.027. Epilepsy Res. 2006. PMID: 16377146 Review.
Cited by
-
Tested and reported executive problems in children and youth epilepsy.Brain Behav. 2018 Apr 16;8(5):e00971. doi: 10.1002/brb3.971. eCollection 2018 May. Brain Behav. 2018. PMID: 29761020 Free PMC article.
-
Stopping antiepileptic drugs: when and why?Curr Treat Options Neurol. 2010 Sep;12(5):434-42. doi: 10.1007/s11940-010-0083-8. Epub 2010 Jun 26. Curr Treat Options Neurol. 2010. PMID: 20730110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical